TCT 434: Clinical Update on a Novel Completely Extravascular Temporary Pacing Lead System
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Equity/Stock(s)/Options - AtaCor Medical
- Scientific Advisory Board - AtaCor Medical